BriaCell Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
BriaCell Therapeutics Operating Expenses Growth & History (BCTX)
BriaCell Therapeutics's operating expenses was $27.2M for fiscal 2025.
View full BriaCell Therapeutics company overviewBriaCell Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-07-31 | $27.2M | −$6.1M | −18.38% |
| 2024 | 2024-07-31 | $33.3M | $10.1M | +43.22% |
| 2023 | 2023-07-31 | $23.3M | $8.0M | +52.25% |
| 2022 | 2022-07-31 | $15.3M | $8.3M | +119.19% |
| 2021 | 2021-07-31 | $7.0M | $3.0M | +77.02% |
| 2020 | 2020-07-31 | $3.9M | — | — |
BriaCell Therapeutics quarterly operating expenses
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-04-30 | $7.6M | $1.3M | +20.42% |
| Q2 2026 | 2026-01-31 | $7.5M | $361,823 | +5.05% |
| Q1 2026 | 2025-10-31 | $8.3M | $3.2M | +61.52% |
| Q4 2025 | 2025-07-31 | $8.6M | $2.8M | +48.31% |
| Q3 2025 | 2025-04-30 | $6.3M | −$2.9M | −31.44% |
| Q2 2025 | 2025-01-31 | $7.2M | −$2.7M | −27.06% |
| Q1 2025 | 2024-10-31 | $5.2M | −$3.4M | −39.40% |
| Q4 2024 | 2024-07-31 | $5.8M | −$1.9M | −25.15% |
| Q3 2024 | 2024-04-30 | $9.2M | $3.6M | +62.58% |
| Q2 2024 | 2024-01-31 | $9.8M | $5.3M | +119.10% |
| Q1 2024 | 2023-10-31 | $8.5M | $3.1M | +57.37% |
| Q4 2023 | 2023-07-31 | $7.7M | — | — |
| Q3 2023 | 2023-04-30 | $5.7M | $1.6M | +37.68% |
| Q2 2023 | 2023-01-31 | $4.5M | $839,514 | +23.02% |
| Q1 2023 | 2022-10-31 | $5.4M | $3.1M | +136.48% |
| Q3 2022 | 2022-04-30 | $4.1M | −$683,393 | −14.22% |
| Q2 2022 | 2022-01-31 | $3.6M | $3.5M | +1817.90% |
| Q1 2022 | 2021-10-31 | $2.3M | — | — |
| Q3 2021 | 2021-04-30 | $4.8M | — | — |
| Q2 2021 | 2021-01-31 | $190,146 | — | — |
BriaCell Therapeutics operating expenses trends
Over the last five fiscal years, BriaCell Therapeutics's operating expenses increased from $3.9M to $27.2M, a change of $23.3M. The latest reported quarter, Q3 2026, shows $7.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BriaCell Therapeutics source filings ↗